A flurry of recent products suggests ELTIF 2.0 is gaining traction with managers and investors alike.

With Kaiser Permanente returning to market with its third billion-plus portfolio in as many years and more first-timers taking the plunge, secondaries players are hopeful more LPs will take a regular approach to the strategy in the years to come.

Though the stars seem to be aligning for India’s private equity market, the absence of consistent DPI remains a stumbling block.